Fernando, Pilar Gina E.

HRN: 21-23-14  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/20/2022
MUPIROCIN 2%, 15G (TUBE)
04/20/2022
04/26/2022
TOPICAL
15mg
BID
Infected Post-op Wound
Waiting Final Action 

Indication:  Prophylaxis    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: